Proposal of Optomed’s Nomination Board
New shares subscribed for in Optomed Plc’s directed share issue have been registered in the Finnish Trade Register
Inside information: Optomed Plc successfully completes directed share issue raising approximately EUR 6.
Optomed Plc: Interim Report, January – September 2025
Optomed Plc - Managers' transactions - Himberg
Optomed Plc - Managers' transactions - Piila
Optomed Plc - Managers' transactions - Myllylä
Optomed Plc - Managers' transactions - Knuutti
Optomed’s Board has resolved upon a new option plan
Composition of Optomed’s Nomination Board
Change in Optomed’s holding of treasury shares
Optomed Plc - Managers' transactions - Tauriainen
Optomed Plc - Managers' transactions - Calarco
Optomed Plc - Managers' transactions - Wen
Optomed Plc - Managers' transactions - Mäkinen
Optomed Plc - Managers' transactions - Salonen
Optomed Plc - Managers' transactions - Badlani
Optomed Plc - Managers' transactions - Lee
Optomed’s financial reporting in 2026
Optomed Plc: Half-year Report, January – June 2025
Decisions of the Annual General Meeting
Correction to the pdf-version of Optomed's Annual Report
Optomed Plc: Interim Report, January – March 2025
NOTICE OF THE ANNUAL GENERAL MEETING OF OPTOMED PLC
Optomed Annual Report 2024 published
Optomed Plc: Financial Statements Bulletin, January – December 2024
Inside information, profit warning: Optomed receives a large order in the US and increases its full year outlook
Optomed Plc: Interim Report, January – September 2024
Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings
Inside information, profit warning: Optomed decreases its full year outlook
Optomed Plc - Managers' transactions - Tenstam
Optomed’s financial reporting in 2025
Optomed Plc: Half-year Report, January – June 2024
Inside information: Optomed Plc successfully completes directed share issue raising approximately EUR 7.
Inside Information: Optomed has signed a shareholder’s agreement with Zhongbao Fund to establish a joint venture in China
Decisions of the Annual General Meeting and Board of Directors
Optomed Plc: Interim Report, January – March 2024
Inside information, Optomed Aurora with AEYE has received FDA clearance in the US
No updates on the Optomed Aurora AEYE FDA clearance process
Notice of the Annual General Meeting of Optomed Plc
Optomed Annual Report 2023 published
Optomed Plc: Financial Statements Bulletin, January – December 2023
Optomed Plc: Interim report, January – September 2023
Inside information: Optomed Plc successfully completes directed share issue raising EUR 4.
Optomed’s financial reporting in 2024
Optomed Plc: Half-year Report, January – June 2023
Inside information, Juho Himberg has been appointed CEO of Optomed
Inside information: Optomed announces CEO transition plan
Change in Optomed’s holding of treasury
Optomed Plc: Interim Report, January – March 2023
Optomed Annual Report 2022 published
Optomed Plc: Financial statements bulletin, January – December 2022
Optomed Plc - Managers' Transactions
Optomed Plc: Financial Statements Bulletin, January – December 2021
Correction: Optomed Announces Clinical Trial Results
Optomed Announces Clinical Trial Results